Natera inked a collaboration deal with biotech Angiex to assess the use of its Signatera blood test, which looks for small traces of cancer DNA in patients who have been diagnosed and treated for the disease.
Natera teams with Angiex on cancer drug trial monitoring
Post navigation
Previous Post
Methylation puts parasites in motion